Serial 79251606
Live / Registered — Registered (as of 22 Oct 2019)
What this means for you
Registered since 22 Oct 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79251606
- Registration number
- 5887717
- Mark type
- Design / logo
- Filed
- 04 Sept 2018
- Published for opposition
- 06 Aug 2019
- Registered
- 22 Oct 2019
- Attorney of record
- Alexandra MacKay
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical substances and preparations for human use, namely, for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes; biopharmaceutical substances and preparations for human use, namely, for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes
- Class 042 — Scientific and technological services: Medical, scientific and industrial scientific research services; pharmaceutical and biopharmaceutical research and development services; laboratory analysis and testing services in the field of gene expression; development, laboratory analysis and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, laboratory analysis and testing of medicaments; development of test systems for pharmaceutical and biopharmaceutical products; development of databases in the medical, pharmaceutical and biopharmaceutical field and development of computer data banks containing information concerning gene expression and gene therapy; pharmaceutical drug development services
- Class 044 — Medical, beauty and agricultural services: Medical services; medical and pharmaceutical advisory and consultancy services
Owner
- Galapagos N.V., BE
- Galapagos N.V., BE
- Galapagos N.V., BE
Prosecution history
- 22 Oct 2024 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 15 May 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 06 Mar 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 13 Feb 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 12 Feb 2020 — FINAL DISPOSITION PROCESSED
- 22 Jan 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 22 Oct 2019 — REGISTERED-PRINCIPAL REGISTER
- 16 Aug 2019 — NOTIFICATION PROCESSED BY IB
- 06 Aug 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2019 — PUBLISHED FOR OPPOSITION
- 31 Jul 2019 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 31 Jul 2019 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 17 Jul 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Jul 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jun 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED